Amid deepening addiction crisis, FDA approves powerful new opioid

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approve...

Posted: Nov 5, 2018 2:06 AM
Updated: Nov 5, 2018 2:06 AM

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl.

Dsuvia, made by AcelRx Pharmaceuticals Inc., is a tablet in a single-dose, prefilled applicator to be administered under the tongue by health care providers to patients in settings such as hospitals, surgical centers and emergency rooms, according to the company.

Business and industry sectors

Business, economy and trade

Controlled substances

Drugs and society

Epidemics and outbreaks

Government organizations - US

Health and medical

Opioid epidemic

Opioids

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Prescription drug abuse

Public health

Society

Substance abuse

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Drug overdoses

Medical treatments and procedures

Pain management

Consumer protection

Drug and medical devices approval

Pharmaceuticals and biotechnology regulation and policy

FDA Commissioner Dr. Scott Gottlieb was quick to defended the approval in a statement Friday: "The agency is taking new steps to more actively confront this crisis, while also paying careful attention to the needs of patients and physicians managing pain."

In April, Gottlieb told CNN Chief Medical Correspondent Dr. Sanjay Gupta that opioids are the biggest crisis facing the nation, a crisis fueled by overprescribing. The numbers say it all: More people die in the US each year from drug overdoses than from breast cancer.

Following the approval of Dsuvia, Gottlieb acknowledged that opioids are a unique class of medications. "I recognize that the debate goes beyond the characteristics of this particular product or the actions that we're taking to mitigate this drug's risks and preserve its differentiated benefits. We won't sidestep what I believe is the real underlying source of discontent among the critics of this approval -- the question of whether or not America needs another powerful opioid while in the throes of a massive crisis of addiction," he said.

But the criticism was quick. "The U.S. Food and Drug Administration (FDA) is recklessly and needlessly endangering people by approving a super-strong opioid," a statement from the public advocacy group Public Citizen said in response to the approval. The group noted that Dsuvia is five to 10 times more powerful than fentanyl and 1,000 times more potent than morphine.

"It is certain that Dsuvia will worsen the opioid epidemic and kill people needlessly," said Dr. Sidney Wolfe, founder and senior adviser of Public Citizen's Health Research Group.

"DSUVIA will not be available in retail pharmacies or for outpatient use. DSUVIA will only be distributed to health care settings certified in the DSUVIA Risk Evaluation and Mitigation Strategy (REMS) program following attestation by an authorized representative that the healthcare setting will comply with appropriate dispensing and use restrictions of DSUVIA," AcelRx said.

Other restrictions, according to the FDA, include that it cannot be used for more than 72 hours and will have the same black-box warnings as are required for all opioids about the risk of misuse and abuse that can lead to addiction and overdose death.

"Because of the risks of addiction, abuse and misuse with opioids; Dsuvia is also to be reserved for use in patients for whom alternative pain treatment options have not been tolerated, or are not expected to be tolerated, where existing treatment options have not provided adequate analgesia, or where these alternatives are not expected to provide adequate analgesia," according to a statement from Gottlieb about the drug's approval.

The statement noted the benefit the drug could have for soldiers injured on the battlefield. It notes that the Department of Defense was involved in its development and that it was a priority for the Pentagon because it "fills an unmet need."

The same drug, with the chemical name sufentanil, is already available as an IV medication. In its newly approved form, it is an option for patients with acute pain who are not able to receive an IV or are unable to swallow a pill. Dsuvia was approved by the European Medicines Agency in June under the name Dzuveo.

Dsuvia was rejected by an FDA advisory committee in 2017 because the committee wanted more data. AcelRx returned to the committee this year, and on October 12 the drug was recommended for approval. It is expected to be available in the first quarter of next year.

"As a single-dose, non-invasive medication with a rapid reduction in pain intensity, DSUVIA represents an important alternative for healthcare providers to offer patients for acute pain management," Dr. David Leiman, clinical assistant of surgery at University of Texas at Houston, said in a statement from AcelRx. Leiman was a researcher on an AcelRx study of Dsuvia in post-surgical patients.

Huntsville
Few Clouds
73° wxIcon
Hi: 93° Lo: 71°
Feels Like: 73°
Florence
Clear
74° wxIcon
Hi: 97° Lo: 74°
Feels Like: 74°
Fayetteville
Clear
70° wxIcon
Hi: 92° Lo: 72°
Feels Like: 70°
Decatur
Clear
69° wxIcon
Hi: 94° Lo: 72°
Feels Like: 69°
Scottsboro
Few Clouds
70° wxIcon
Hi: 92° Lo: 72°
Feels Like: 70°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Confirmed Cases: 94827

Reported Deaths: 1674
CountyConfirmedDeaths
Jefferson12969243
Mobile9836206
Montgomery6609148
Madison531433
Tuscaloosa419073
Unassigned356061
Baldwin350224
Shelby326035
Marshall313035
Lee266045
Morgan236918
Etowah210431
DeKalb179813
Calhoun176113
Elmore171538
Walker152064
Houston138612
Russell13582
St. Clair132817
Dallas131823
Limestone131813
Franklin127020
Cullman122012
Colbert117113
Lauderdale115717
Autauga108621
Escambia107516
Talladega100913
Jackson9684
Tallapoosa85479
Chambers84038
Dale82723
Blount7884
Chilton7886
Butler75836
Coffee7566
Covington73420
Pike7037
Clarke6629
Barbour5735
Lowndes57124
Marion57024
Marengo55315
Hale47326
Bullock46311
Winston45011
Perry4404
Bibb4265
Wilcox42610
Monroe4194
Randolph39610
Pickens3929
Conecuh38810
Washington38612
Sumter36018
Lawrence3481
Macon33414
Crenshaw3143
Choctaw28112
Cherokee2707
Henry2593
Geneva2570
Clay2525
Greene25011
Lamar2202
Fayette2045
Cleburne1261
Coosa1012
Out of AL00

Tennessee Coronavirus Cases

Confirmed Cases: 120585

Reported Deaths: 1215
CountyConfirmedDeaths
Shelby22916301
Davidson20383213
Rutherford646354
Hamilton606253
Knox451338
Williamson347825
Sumner340473
Unassigned312810
Out of TN286014
Wilson226223
Bradley190312
Montgomery190213
Sevier18507
Putnam174018
Trousdale15826
Robertson153519
Hamblen138314
Blount127711
Maury12257
Washington12252
Tipton11959
Madison106417
Sullivan96214
Bedford91811
Hardeman89817
Macon85813
Lake7820
Loudon7253
Bledsoe6951
Gibson6935
Fayette6868
Dickson6792
Anderson6766
Dyer6287
Cheatham5787
Henderson5632
Jefferson5593
Lawrence5506
Obion5464
McMinn53120
Rhea5282
Coffee5223
Carter5126
Warren5074
Lauderdale4898
Greene4678
Haywood4636
Hardin4628
Roane4612
Cocke4572
Hawkins4517
Cumberland4506
Smith4454
Weakley4214
Monroe4189
Giles37813
McNairy3715
DeKalb3492
Franklin3254
Carroll2963
Marshall2903
White2815
Lincoln2801
Henry2760
Claiborne2660
Crockett2664
Johnson2650
Hickman2590
Campbell2471
Wayne2252
Marion2224
Chester2172
Polk2043
Decatur1983
Grainger1960
Overton1801
Unicoi1610
Union1540
Benton1481
Cannon1430
Jackson1241
Humphreys1203
Morgan1181
Scott1180
Grundy1132
Sequatchie1050
Meigs1040
Fentress920
Perry790
Hancock782
Clay750
Stewart740
Lewis731
Moore610
Houston570
Van Buren360
Pickett311

Community Events